More recently, Asano et al. described increased PD-L1 expression to be associated with reduced Ki-67 [107], which is perhaps unsurprising as simple measures of PD-L1 expression does not capture differential enrichments across patients, tumour, and immune cell subtypes, as well as the spatial proximity of these cell types within tissues. This evidence concerns the gene CD274 and neoplasm.